FOS antisense RNA 1 (FOS-AS1)

FOS antisense RNA 1 (FOS-AS1) is a **long non-coding RNA (lncRNA)** transcribed from the opposite DNA strand of the FOS gene locus. It does not code for a protein. Like other antisense lncRNAs, FOS-AS1 can regulate the expression of its overlapping or nearby sense gene (FOS), typically through mechanisms such as recruiting transcription factors, forming RNA duplexes with sense transcripts, and affecting mRNA stability or translation. These regulatory actions can influence essential cellular processes including cell proliferation, apoptosis, and differentiation, with implications for diseases such as cancer[1][3]. Antisense lncRNAs are widely researched as potential **biomarkers** or **therapeutic targets**, but FOS-AS1 itself is not yet an established direct therapeutic or drug target in clinical medicine. Context and limitations: - The specific biological and clinical roles of FOS-AS1 have not been as extensively characterized as for some other antisense lncRNAs. Most information is inferred from general properties of antisense lncRNAs, which function as regulators rather than canonical therapeutic targets like receptors, enzymes, or ion channels[1][3]. - There is some experimental research using antisense RNA against c-FOS (the protein-coding gene), showing effects on cancer cell phenotypes[2], but this does not directly make FOS-AS1 itself a clinical drug target. Summary: FOS-AS1 is a non-coding antisense RNA involved in gene regulation but is not currently considered a canonical therapeutic target such as a receptor or enzyme. Its interest is primarily in research on gene regulation and cancer biology, especially as a potential biomarker, rather than as a direct target for small molecule or biologic drugs.

Other names

FOS-AS1FOS antisense lncRNA 1FOS-AS

Not applicable (no known direct-acting drugs); general mechanisms include transcriptional and post-transcriptional gene regulation[1][3].